Drugs / dehydrated human amnion membrane
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03864939 | Apr 2019 → Apr 2024 | — | German Centre for Assessment and Evaluation of Innovative Techniques in Medicine | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dehydrated human amnion membrane | “A dehydrated human amnion membrane (dHAM, 1x3cm) is placed around the neurovascular bundle (NVB) on the left and right side and vesicourethral anastomosis (VUA) during radical...” NCT03864939 ↗ |
| Known as | dHAM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03864939 ↗ |